Literature DB >> 11135212

Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma.

G Farshid1, M Pradhan, J Kollias, P G Gill.   

Abstract

BACKGROUND: Many empiric protocols are used to detect metastases in sentinel lymph nodes (SLNs), but comparison of the efficacy of these methods is impractical because tissue is lost in processing, making reassessment with another policy difficult. Consequently, performance indicators of this test are largely unknown.
DESIGN: The authors retrospectively examined 112 SLNs removed from 89 patients with breast carcinoma treated at the authors' institution and used the histologic data to devise a mathematic model of a SLN with Matlab modeling software. The authors simulated examination of this computer-generated (virtual) lymph node according to several macroscopic and histologic sampling protocols and for each protocol assessed the probability of detecting micrometastases of specified sizes. The authors used published costing figures to estimate the cost of the policies.
RESULTS: Direct comparison of 6 sectioning strategies currently in use by pathology laboratories showed the chances of detecting a 500-microm metastasis ranged from 20% to 75%. Four of the 6 protocols had a less than 30% chance of detecting metastases of this size. The detection rate of smaller metastases was poorer. Cost was not a good discriminator because some policies were more efficient than others.
CONCLUSIONS: The detection of metastases is highly dependent on the methods used to look for them. The authors' simulations suggest that commonly used methods of examining lymph nodes have high false-negative rates, particularly for small metastases. There is an urgent need for pathologists and clinicians to agree on the minimum size of SLN metastases that will be sought by histology and set standard methods for examining these lymph nodes. Copyright 2000 American Cancer Society.

Entities:  

Mesh:

Year:  2000        PMID: 11135212

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  Strategies for optimizing pathologic staging of sentinel lymph nodes in breast cancer patients.

Authors:  Eva V E Madsen; Jan van Dalen; Joost van Gorp; Inne H M Borel Rinkes; Thijs van Dalen
Journal:  Virchows Arch       Date:  2008-06-18       Impact factor: 4.064

2.  Metastasis detection in sentinel lymph nodes: comparison of a limited widely spaced (NSABP protocol B-32) and a comprehensive narrowly spaced paraffin block sectioning strategy.

Authors:  Donald L Weaver; Uyen Phuong Le; Stacey L Dupuis; Katherine A E Weaver; Seth P Harlow; Takamaru Ashikaga; David N Krag
Journal:  Am J Surg Pathol       Date:  2009-11       Impact factor: 6.394

3.  [Optimization of staging in colon cancer using sentinel lymph node biopsy].

Authors:  A Bembenek; U Schneider; S Gretschel; C Ulmer; P M Schlag
Journal:  Chirurg       Date:  2005-01       Impact factor: 0.955

Review 4.  The role of lymph node density in bladder cancer prognostication.

Authors:  Marcus L Quek; Robert C Flanigan
Journal:  World J Urol       Date:  2008-11-20       Impact factor: 4.226

5.  The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer.

Authors:  M B Klevesath; L G Bobrow; S E Pinder; A D Purushotham
Journal:  Br J Cancer       Date:  2005-06-20       Impact factor: 7.640

6.  Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'--a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase.

Authors:  Vinod B Shidham; Dan Qi; R Nagarjun Rao; Scott M Acker; Chung-Che Chang; Bal Kampalath; Glen Dawson; Jinobya K Machhi; Richard A Komorowski
Journal:  BMC Cancer       Date:  2003-05-07       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.